文献速递肺结节与肺癌

低风险I期肺腺癌术后复发预测模型的建立与验证

Prediction model on disease recurrence for low risk resected stage I lung adenocarcinoma.
PubMed 文献 · Respirology · 2023-04-27

本研究回顾性分析408例2013至2017年根治性切除的低风险I期肺腺癌患者的无病生存期(DFS),采用树状分区结合多因素分析构建基于吸烟状态、疾病分期和性别的评分系统预测复发,并在2011至2012年队列中验证。模型将患者分为3个DFS显著不同的风险组,外部验证AUC为0.863(95%CI 0.755-0.972),有助于个体化随访和辅助治疗。

要点

  • 不吸烟、IA期、EGFR突变和女性与更好的DFS相关
  • 基于吸烟状态、分期和性别的评分系统分出3个DFS显著不同的风险组
  • 外部验证AUC为0.863,模型可辅助个体化随访策略

核心结论

  • 基于常规临床信息的模型可对I期肺腺癌术后患者进行风险分层,可能有助于个体化随访策略和未来辅助治疗。

研究设计与样本

  • 回顾性研究,纳入408例2013至2017年病理确诊的低风险I期肺腺癌根治性切除患者,采用树状方法分区并多因素分析构建评分系统,用2011至2012年队列外部验证。

主要发现

  • 不吸烟状态、IA期疾病、表皮生长因子受体(EGFR)突变和女性与更好的DFS相关。
  • 多因素分析确定吸烟状态、疾病分期和性别为评分系统必要因素,分出3个DFS显著不同的风险组,DFS分别为99.4(95%CI 78.3-125.3)、62.9(95%CI 48.2-82.0)、33.7(95%CI 24.6-46.1)个月,p < 0.005。
  • 外部验证的受试者工作特征曲线下面积(AUC)为0.863(95%CI 0.755-0.972)。

临床怎么用

  • 可利用吸烟状态、疾病分期和性别对I期肺腺癌术后患者进行复发风险分层,辅助制定个体化随访策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVE: Although stage I non-small cell lung carcinoma (NSCLC) typically carries a good prognosis following complete resection, early disease recurrence can occur. An accurate survival prediction model would help refine a follow-up strategy and personalize future adjuvant therapy. We developed a post-operative prediction model based on readily available clinical information for patients with stage I adenocarcinoma. METHODS: We retrospectively studied the disease-free survival (DFS) of 408 patients with pathologically confirmed low-risk stage I adenocarcinoma of lung who underwent curative resection from 2013 to 2017. A tree-based method was employed to partition the cohort into subgroups with distinct DFS outcome and stepwise risk ratio. These covariates were included in multivariate analysis to build a scoring system to predict disease recurrence. The model was subsequently validated using a 2011-2012 cohort. RESULTS: Non-smoker status, stage IA disease, epidermal-growth factor receptor mutants and female gender were associated with better DFS. Multivariate analysis identified smoking status, disease stage and gender as factors necessary for the scoring system and yielded 3 distinct risk groups for DFS [99.4 (95% CI 78.3-125.3), 62.9 (95% CI 48.2-82.0), 33.7 (95% CI 24.6-46.1) months, p < 0.005]. External validation yielded an area under the curve by receiver operating characteristic analysis of 0.863 (95% CI 0.755-0.972). CONCLUSION: The model could categorize post-operative patients using readily available clinical information, and may help personalize a follow-up strategy and future adjuvant therapy.

来源:Respirology,查看原文。版权归原作者所有。

引用

  1. Kwok WC, Ma TF, Ho JCM, et al. Prediction model on disease recurrence for low risk resected stage I lung adenocarcinoma. Respirology. 2023. PMID: 37106570. doi:10.1111/resp.14508

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。